Press "Enter" to skip to content

Amylyx drug helps slow ALS progression in mid-stage study

ALS, also known as Lou Gehrig’s disease, is a rare disorder that attacks nerve cells responsible for controlling voluntary muscles, and over 6,000 Americans are diagnosed with the disease every year, according to the ALS Association.

Original source:

Also Read:   Lupin gets 6 observations from USFDA for its Pithampur Unit-2